Correspondence 0001104659-23-116851 from PSYENCE BIOMEDICAL LTD. (PBM)
PSYENCE BIOMEDICAL LTD.
Date: Nov. 13, 2023 · CIK: 0001985062 · Accession: 0001104659-23-116851
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273553
Letter
Psyence Biomedical Ltd.
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario M5H 2K1
+1 (416) 346-7764
November 13, 2023
VIA EDGAR
Division of Corporation Finance
Office of Life Sciences
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549
RE: Psyence Biomedical Ltd. (the “Company”)
Registration Statement on Form F-4, as amended
(File No. 333-273553) (the “Registration Statement”)
Ladies and Gentlemen:
The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:00 p.m. EST on November 13, 2023, or as soon thereafter as practicable.
Please contact Ari Edelman of McDermott Will & Emery LLP, counsel to Newcourt Acquisition Corp, at (212) 547-5372 as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.
Very truly yours,
Psyence Biomedical Ltd.
Show Raw Text
CORRESP
1
filename1.htm
Psyence Biomedical Ltd.
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario M5H 2K1
+1 (416) 346-7764
November 13, 2023
VIA
EDGAR
Division of Corporation Finance
Office of Life Sciences
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, D.C. 20549
RE:
Psyence Biomedical Ltd. (the “Company”)
Registration Statement on Form F-4, as amended
(File No. 333-273553) (the “Registration Statement”)
Ladies and Gentlemen:
The Company hereby requests,
pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration
Statement so that such Registration Statement will become effective as of 4:00 p.m. EST on November 13, 2023, or as soon thereafter
as practicable.
Please contact Ari Edelman
of McDermott Will & Emery LLP, counsel to Newcourt Acquisition Corp, at (212) 547-5372 as soon as the Registration Statement
has been declared effective, or if you have any other questions or concerns regarding this matter.
Very truly yours,
Psyence Biomedical Ltd.
By:
/s/ Neil Maresky
Name:
Neil Maresky
Title:
Chief Executive Officer
cc:
McDermott Will & Emery LLP
Ellenoff Grossman & Schole LLP